NCT05757219
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Clinical trial condition
Diffuse Large B Cell Lymphoma
Explore clinical trials studying Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.
165 public trials
53 recruiting studies
Diffuse Large B Cell Lymphoma trial results
NCT05006716
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
NCT07225439
- Conditions
- B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
- Locations
-
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
NCT06687772
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT06227026
- Conditions
- Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Hematologic Diseases, +14 more
- Locations
-
- Huntsman Cancer Institute Salt Lake City, Utah, United States
NCT05887167
- Conditions
- Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +28 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT06533579
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
- Locations
-
- City of Hope Duarte, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- New York Medical College Valhalla, New York, United States
Recruiting
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
NCT05990465
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma, +23 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT05820841
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Saarland University Medical Center Homburg, Saarland, Germany
- MVZ am Klinikum Aschaffenburg Aschaffenburg, Germany
- Helios Klinikum Emil von Behring Berlin, Germany
- Onkologische Schwerpunktpraxis Kurfürstendamm Berlin, Germany
Recruiting
Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?
NCT06352242
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Clinical hematology department, University Hospital Montpellier, France
- Clinical Investigation Center, University Hospital Montpellier, France